Unwanted guests: How herpes simplex virus gets rid of the cell’s security guards

A viral infection is like an uninvited, tenacious houseguest in the cell, using a range of tricks to prevent its eviction. Researchers at the Salk Institute for Biological Studies have identified one of the key proteins allowing herpes simplex virus (HSV) DNA to fly under the radar of their hosts' involuntary...

NanoBio inks $54.5M development deal with GSK

Ann Arbor, MI-based NanoBio has inked a deal with GlaxoSmithKline for an experimental cold sore therapy poised to go into late-stage testing. NanoBio picks up a $14.5 million upfront payment and stands to earn up to $40 million in milestones and single digit royalties on any marketed therapy. "GSK's demonstrated leadership in developing and marketing consumer healthcare products, including the leading product for the treatment of herpes labialis, makes them the ideal partner for...